Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06751069 · ClinicalTrials.gov registry record · NA
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
A NA study of Lung Fibrosis and Lung Interstitial Disease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 460
- Enrollment target
- 4
- Study locations
NCT06751069 is a NA study of Lung Fibrosis and Lung Interstitial Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 460 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT06751069, a NA study of Lung Fibrosis and Lung Interstitial Disease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.
Conditions Studied
Interventions
- BEHAVIORAL Home-based Pulmonary Rehab
Study Locations (4)
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic in Rochester - Rochester
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2030-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06751069
The ClinicalTrials.gov registry entry for NCT06751069 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Home-based Pulmonary Rehab is the first listed.
NCT06751069 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT06751069 about?
NCT06751069 is a clinical study titled "Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease". The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.
What is the current status of trial NCT06751069?
This trial is currently recruiting. It is a NA study. The enrollment target is 460 participants. The study started on 2025-03-03. Estimated completion is 2030-09-30.
What conditions does trial NCT06751069 study?
This clinical trial studies the following conditions: Lung Fibrosis, Lung Interstitial Disease.
What interventions are being tested in trial NCT06751069?
The interventions under investigation include: Home-based Pulmonary Rehab (BEHAVIORAL).
Who is sponsoring clinical trial NCT06751069?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06751069 being conducted?
This trial has 4 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.